Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K
RNA Editing02:23

RNA Editing

9.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.9K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

207
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
207
RNA Interference01:23

RNA Interference

28.2K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.2K
RNA Structure01:23

RNA Structure

79.2K
Overview
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...
79.2K
RNA Stability01:53

RNA Stability

35.8K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.8K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Cyclic nucleotide phosphodiesterases as drug targets.

Pharmacological reviews·2025
Same author

Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice.

Gut microbes·2024
Same author

Back to phosphodiesterase inhibitors for liver disease: Are we ready for clinical trials?

Hepatology (Baltimore, Md.)·2024
Same author

Association of Circulating Markers of Microbial Translocation and Hepatic Inflammation with Liver Injury in Patients with Type 2 Diabetes.

Biomedicines·2024
Same author

Hepatocyte-specific mitogen-activated protein kinase phosphatase 1 in sexual dimorphism and susceptibility to alcohol induced liver injury.

Frontiers in immunology·2024
Same author

GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis.

Military Medical Research·2024

関連する実験動画

Updated: Feb 9, 2026

Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data
07:35

Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data

Published on: December 1, 2023

1.2K

長鎖非コードRNA H19の肝臓発生および疾患における役割

Diego Elias Montoya-Durango1, Leila Gobejishvili1

  • 1Department of Physiology, University of Louisville School of Medicine, Louisville, KY 40202, United States of America; Alcohol Research Center, University of Louisville School of Medicine, Louisville, KY 40202, United States of America.

Cellular signalling
|February 7, 2026
PubMed
まとめ

長鎖非コードRNA H19遺伝子は、肝臓の発生と疾患において重要である。成人の肝臓での再発現は、脂肪肝、線維症、癌を促進し、その治療の可能性を強調する。

科学分野:

  • 分子生物学
  • 肝臓学
  • 遺伝学

背景:

  • 肝疾患は年間200万人以上の死因となっており、MASLDとALDが主な原因である。
  • 食事とアルコールは、脂肪症、線維症、肝硬変、肝細胞癌などの肝臓の病状を駆動する。
  • 肝臓損傷に対する治療選択肢が限られているため、新しい治療法が急務である。

研究 の 目的:

  • H19遺伝子の肝臓発生における多面的な役割をレビューする。
  • 脂肪肝、線維症、肝細胞癌を含む肝疾患におけるH19の関与を要約する。
  • 代謝、線維症、細胞周期、クロマチンにおけるH19の調節機能を探索する。

主な方法:

  • 肝臓の発生と疾患におけるH19遺伝子の機能に関する研究の文献レビュー。
  • H19とタンパク質、コードRNA、非コードRNAとの相互作用の分析。
  • H19のエピジェネティック制御と肝臓の病状への影響の要約。

主要な成果:

  • H19は、胚発生および新生仔の肝臓成熟に不可欠である。
  • 成人の肝臓でのH19再発現は、脂肪生成、線維症を駆動し、腫瘍細胞の増殖を維持する。
  • H19は、代謝、線維症、細胞周期、クロマチンを調節する多数の分子と相互作用する。
キーワード:
線維症脂質代謝肝臓肝臓癌肝障害長鎖非コードRNA H19

さらに関連する動画

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
13:04

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Published on: March 1, 2019

9.3K
Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
09:27

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

4.0K

関連する実験動画

Last Updated: Feb 9, 2026

Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data
07:35

Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data

Published on: December 1, 2023

1.2K
Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
13:04

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Published on: March 1, 2019

9.3K
Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
09:27

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

4.0K

結論:

  • H19は、肝臓の発生に不可欠であるが、成人の肝疾患では病原性を示すという二重の役割を果たす。
  • H19の複雑な機能を理解することは、肝疾患の新しい治療戦略を開発するための鍵である。
  • H19を標的とすることは、メタボリック機能障害関連脂肪肝疾患および肝細胞癌の治療のための新しいアプローチを提供する可能性がある。